Development and validation of a prognostic model predicting the prognosis of surgically treated non-clear cell renal cell carcinoma patients with tumor thrombus
He Miao(Nanjing General Hospital of Nanjing Military Command), Le Qu(Nanjing General Hospital of Nanjing Military Command), Xing Zeng(Tongji Hospital), Silun Ge(Nanjing General Hospital of Nanjing Military Command), Xin Pan(Henan Normal University), Hui Chen(Nanjing General Hospital of Nanjing Military Command), Yufeng Gu(Nanjing General Hospital of Nanjing Military Command), Linhui Wang(Second Military Medical University), Shaogang Wang(Tongji Hospital), Jingping Ge(Nanjing General Hospital of Nanjing Military Command), Wenquan Zhou(Nanjing General Hospital of Nanjing Military Command), Chang Lei(Nanjing General Hospital of Nanjing Military Command), Ye Zhou(Second Military Medical University), Yulin Zhou(Nanjing General Hospital of Nanjing Military Command), Cheng Zhao(Central South University)
Cited by 0
Related Papers
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
|Cancer Cell|2016|1.2k
Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
|Biomaterials|2021|1.1k
Mesoporous silica nanoparticles for drug and gene delivery
|Acta Pharmaceutica Sinica B|2018|691
Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling
|Molecular Cancer|2017|257
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247